A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis
Clinical trial NCT02718898 · COMPLETED
Trial details
- NCT number
- NCT02718898
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-02-22
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.